For patients and practitioners who are looking beyond conventional treatment to address the neurocognitive effects of dementia, quercetin, butyrate, and glutathione may offer significant benefits.
As the dangers of oxidative stress become increasingly evident, there is reason to believe that lowering this stress via glutathione supplementation could help patients optimize well-being.
Though GABA’s impact in the body is well-understood, far less is known about the efficacy or side effects of GABA supplements, and patients may wish to investigate alternative supplementation for greater therapeutic potential and known safety.
Several supplements have recently been investigated as potential methods of preventing or mitigating Parkinson’s disease, and their early promise in helping patients protect their health is undeniable.
Early studies suggest that glutathione may aid in the prevention and/or management of a wide variety of serious conditions, ranging from neurological diseases and gastrointestinal conditions to aging skin.
While IV administration of glutathione has few side effects, it may not be the optimal treatment solution when it comes to the patient’s lifestyle concerns, like those with Parkinson’s disease and autism spectrum disorder,
The benefits of curcumin stem primarily from its anti-inflammatory and antioxidant activities, but it also has antimicrobial and protein regulatory properties that further expand its potential benefits as a therapy.
Many researchers now recognize the role of the gut-brain axis in the onset and development of Parkinson’s disease, spurring growing interest in a microbiome diet to help ameliorate symptoms and slow progression.
Thanks to curcumin’s impact on inflammation, immune cells, and the body’s response to stress, patients may have the ability to prevent or slow the progression of neurodegenerative conditions such as Alzheimer’s and Parkinson’s.
Glutathione supplementation may an attractive option to protect brain health due to its minimal side effect profile and proven link to cognitive functioning in both healthy people and people with cognitive impairment.